Invention Grant
- Patent Title: Substituted imidazoquinolines
-
Application No.: US16644076Application Date: 2018-08-31
-
Publication No.: US11267813B2Publication Date: 2022-03-08
- Inventor: Christophe Henry
- Applicant: BIONTECH SE
- Applicant Address: DE Mainz
- Assignee: BIONTECH SE
- Current Assignee: BIONTECH SE
- Current Assignee Address: DE Mainz
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: WOPCT/EP2017/072352 20170906
- International Application: PCT/EP2018/073470 WO 20180831
- International Announcement: WO2019/048350 WO 20190314
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P35/00
Abstract:
The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.
Public/Granted literature
- US20200317663A1 SUBSTITUTED IMIDAZOQUINOLINES Public/Granted day:2020-10-08
Information query
